Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
Yamagata Prefectural Institute of Public Health, Yamagata, Japan.
Microbiol Immunol. 2022 Jul;66(7):361-370. doi: 10.1111/1348-0421.12985. Epub 2022 Jun 8.
The practical use of cell-based seasonal influenza vaccines is currently being considered in Japan. From the perspective of adventitious virus contamination, we assessed the suitability of NIID-MDCK cells (NIID-MDCK-Cs) as a safe substrate for the isolation of influenza viruses from clinical specimens. We first established a sensitive multiplex real-time PCR system to screen for 27 respiratory viruses and used it on 34 virus samples that were isolated by passaging influenza-positive clinical specimens in NIID-MDCK-Cs. Incidentally, the limit of detection (LOD) of the system was 100 or fewer genome copies per reaction. In addition to influenza viruses, human enterovirus 68 (HEV-D68) genomes were detected in two samples after two or three passages in NIID-MDCK-Cs. To further investigate the susceptibility of NIID-MDCK-Cs to adventitious viruses, eight common respiratory viruses were subjected to passages in NIID-MDCK-Cs. The genome copy numbers of seven viruses other than parainfluenza 3 decreased below the LOD by passage 4. By passaging in NIID-MDCK-Cs, the genome numbers of the input HEV-D68, 1 × 10 copies, declined to 10 at passage 3 and to under the LOD at passage 4, whereas those of the other six viruses were under the LOD by passage 3. These results implied that during the process of isolating influenza viruses with NIID-MDCK-Cs, contaminating viruses other than parainfluenza 3 can be efficiently removed by passages in NIID-MDCK-Cs. NIID-MDCK-Cs could be a safe substrate for isolating influenza viruses that can be used to develop cell-based influenza vaccine candidate viruses.
细胞季节性流感疫苗在日本的实际应用目前正在考虑中。从外来病毒污染的角度出发,我们评估了 NIID-MDCK 细胞(NIID-MDCK-Cs)作为从临床标本中分离流感病毒的安全基质的适用性。我们首先建立了一种敏感的多重实时 PCR 系统来筛选 27 种呼吸道病毒,并将其应用于通过在 NIID-MDCK-Cs 中传代流感阳性临床标本分离的 34 个病毒样本。该系统的检测限(LOD)为每个反应 100 个或更少的基因组拷贝。除流感病毒外,在 NIID-MDCK-Cs 中传代两次或三次后,从两个样本中检测到人类肠道病毒 68 型(HEV-D68)基因组。为了进一步研究 NIID-MDCK-Cs 对外来病毒的易感性,将八种常见的呼吸道病毒在 NIID-MDCK-Cs 中进行传代。除副流感 3 型以外的七种病毒的基因组拷贝数在传代 4 次后降至 LOD 以下。通过在 NIID-MDCK-Cs 中传代,输入的 HEV-D68 的基因组数从 1×10 拷贝下降到 3 次传代时的 10 拷贝,到 4 次传代时降至 LOD 以下,而其他六种病毒的基因组数在 3 次传代时已低于 LOD。这些结果表明,在用 NIID-MDCK-Cs 分离流感病毒的过程中,除副流感 3 型以外的污染病毒可以通过在 NIID-MDCK-Cs 中传代来有效去除。NIID-MDCK-Cs 可作为一种安全的基质来分离可用于开发细胞基流感疫苗候选病毒的流感病毒。